News - Brightlands Venture Partners

Naar hoofdinhoud Naar hoofdnavigatiemenu

Search

Matisse Pharmaceuticals raises financing for its phase I/IIa clinical trial treating patients suffering from sepsis

April 03, 2020

Neuroplast raises € 4 million for its stem cell-based technology to treat patients with Spinal Cord Injury

February 17, 2020

Asparagus harvesting robot developer AvL Motion raises € 1 million from Brightlands Agrifood Fund, Future Food Fund and BOM

December 11, 2019

Black Bear announces CEO transition

October 15, 2019

Vacis raises capital from Brightlands Venture Partners, HTGF, LIOF and RVO

October 10, 2019

Breakthrough Technology Takes Plastic From the Ocean and Uses It in a Coca-Cola Bottle

October 04, 2019

Exit: Isobionics acquired by BASF

September 26, 2019

B. Braun Interventional Systems expands its congenital and structural heart portfolio with the Emeryglide MR Conditional Guidewire from Nano4Imaging

September 05, 2019

Cristal Therapeutics appoints Dr Werner Cautreels as a new Director and Board Chairman and Andre Verwei as CFO

August 05, 2019

Grassa raises € 2 million for its innovative biorefinery process

June 11, 2019

Exit: Brightlands Venture Partners sells its stake in Polyscope Polymers

June 03, 2019

Hy2Care raises € 3.7 mln for hydrogel technology to repair cartilage defects

April 30, 2019

More information

If you have any questions or want to know more about us
Contact us